Response Genetics’ Q2 Revenues Climb 39 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Response Genetics reported today that its second quarter revenues increased 39 percent year over year as its pharmaceutical client revenue climbed 121 percent and revenues for its ResponseDX tests increased 10 percent.

For the three months ended June 30, the molecular diagnostics firm reported revenues of $5.3 million, up from $3.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.